<p>Adlai Nortye Ltd. 赞助的 ADR (NASDAQ:ANL - 获取免费报告) 的股价在周三下跌了 11.7%。该股最低交易价为 $7.20，最后交易价为 $13.8410。在午盘交易中，共交易了 967,940 股，较平均交易量 596,093 股增加了 62%。该股之前的收盘价为 $15.68。</p>
<h2>分析师评级调整</h2>
<p>几家券商最近对 ANL 进行了评估。Weiss Ratings 在 1 月 21 日的研究报告中重申了对 Adlai Nortye 的 &#34;卖出 (e+)&#34; 评级。HC Wainwright 将 Adlai Nortye 的评级从 &#34;中性&#34; 上调至 &#34;买入&#34;，并在 2 月 13 日的研究报告中设定了 $16.00 的目标价。Leerink Partners 于 3 月 20 日开始对 Adlai Nortye 进行覆盖。他们对该股给予了 &#34;跑赢大盘&#34; 的评级，并设定了 $23.00 的目标价。最后，Wall Street Zen 在 3 月 7 日的研究报告中将 Adlai Nortye 的评级上调至 &#34;持有&#34;。两位研究分析师给予该股 &#34;买入&#34; 评级，一位给予 &#34;卖出&#34; 评级。根据 MarketBeat.com 的数据，Adlai Nortye 目前的共识评级为 &#34;持有&#34;，平均目标价为 $19.50。</p>
<p><strong>查看我们关于 Adlai Nortye 的最新研究报告</strong></p>
<h2>Adlai Nortye 价格表现</h2>
<p>该公司的 50 日简单移动平均线为 $9.03，200 日简单移动平均线为 $4.44。</p>
<h2>关于 Adlai Nortye</h2>
<p>(获取免费报告)</p>
<p>Adlai Nortye Inc NASDAQ: ANL 是一家总部位于中国江苏省的特种化学品制造商。该公司专注于精细化学品的研究、开发、生产和销售，主要强调氨基酸及其衍生物。</p>
<p>Adlai Nortye 的产品组合包括甜菜碱化合物、一系列高纯度的 L-氨基酸，如 L-蛋氨酸、L-苏氨酸和甘氨酸，以及各种化学中间体。这些产品服务于多个终端市场，包括动物饲料和营养、个人护理和化妆品配方、药用成分和工业化学过程。</p>
<p>该公司在多个生产设施中运营，并设有专门致力于工艺创新和质量控制的内部研发中心。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Adlai Nortye</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 $1,000 在 Adlai Nortye 吗？</h2>
<p>在你考虑 Adlai Nortye 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Adlai Nortye 并不在名单上。</p>
<p>虽然 Adlai Nortye 目前在分析师中获得了 &#34;持有&#34; 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

医药突破 ETF - ALPS

基因改革 ETF - ARK

<p>Adlai Nortye (NASDAQ:ANL) 的股价下跌了 11.7%，至 13.84 美元，交易量增加了 62%，达到 967,940 股。分析师们的意见不一：Weiss Ratings 维持 “卖出” 评级，而 HC Wainwright 将其评级上调至 “买入”，目标价为 16 美元。Leerink Partners 给予 “跑赢大盘” 评级，目标价为 23 美元。目前，市场共识评级为 “持有”，平均目标价为 19.50 美元。Adlai Nortye 专注于精细化学品，特别是氨基酸及其衍生物，服务于包括动物饲料和制药在内的多个市场</p>

<p>Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report)'s stock price fell 11.7% on Wednesday . The stock traded as low as $7.20 and last traded at $13.8410. 967,940 shares were traded during mid-day trading, an increase of 62% from the average session volume of 596,093 shares. The stock had previously closed at $15.68.</p>
<div class="lb-trans"><p>Adlai Nortye Ltd. 赞助的 ADR (NASDAQ:ANL - 获取免费报告) 的股价在周三下跌了 11.7%。该股最低交易价为 $7.20，最后交易价为 $13.8410。在午盘交易中，共交易了 967,940 股，较平均交易量 596,093 股增加了 62%。该股之前的收盘价为 $15.68。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><p>Several brokerages recently weighed in on ANL. Weiss Ratings reiterated a &#34;sell (e+)&#34; rating on shares of Adlai Nortye in a research report on Wednesday, January 21st. HC Wainwright upgraded shares of Adlai Nortye from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and set a $16.00 price objective on the stock in a research report on Friday, February 13th. Leerink Partners began coverage on shares of Adlai Nortye in a research report on Friday, March 20th. They issued an &#34;outperform&#34; rating and a $23.00 price objective on the stock. Finally, Wall Street Zen upgraded shares of Adlai Nortye to a &#34;hold&#34; rating in a research report on Saturday, March 7th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, Adlai Nortye currently has a consensus rating of &#34;Hold&#34; and an average price target of $19.50.</p>
<div class="lb-trans"><p>几家券商最近对 ANL 进行了评估。Weiss Ratings 在 1 月 21 日的研究报告中重申了对 Adlai Nortye 的 &#34;卖出 (e+)&#34; 评级。HC Wainwright 将 Adlai Nortye 的评级从 &#34;中性&#34; 上调至 &#34;买入&#34;，并在 2 月 13 日的研究报告中设定了 $16.00 的目标价。Leerink Partners 于 3 月 20 日开始对 Adlai Nortye 进行覆盖。他们对该股给予了 &#34;跑赢大盘&#34; 的评级，并设定了 $23.00 的目标价。最后，Wall Street Zen 在 3 月 7 日的研究报告中将 Adlai Nortye 的评级上调至 &#34;持有&#34;。两位研究分析师给予该股 &#34;买入&#34; 评级，一位给予 &#34;卖出&#34; 评级。根据 MarketBeat.com 的数据，Adlai Nortye 目前的共识评级为 &#34;持有&#34;，平均目标价为 $19.50。</p>
</div><p><strong>View Our Latest Research Report on Adlai Nortye</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Adlai Nortye 的最新研究报告</strong></p>
</div><h2>Adlai Nortye Price Performance</h2>
<div class="lb-trans"><h2>Adlai Nortye 价格表现</h2>
</div><p>The firm's 50-day simple moving average is $9.03 and its 200 day simple moving average is $4.44.</p>
<div class="lb-trans"><p>该公司的 50 日简单移动平均线为 $9.03，200 日简单移动平均线为 $4.44。</p>
</div><h2>About Adlai Nortye</h2>
<div class="lb-trans"><h2>关于 Adlai Nortye</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Adlai Nortye Inc NASDAQ: ANL is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.</p>
<div class="lb-trans"><p>Adlai Nortye Inc NASDAQ: ANL 是一家总部位于中国江苏省的特种化学品制造商。该公司专注于精细化学品的研究、开发、生产和销售，主要强调氨基酸及其衍生物。</p>
</div><p>Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.</p>
<div class="lb-trans"><p>Adlai Nortye 的产品组合包括甜菜碱化合物、一系列高纯度的 L-氨基酸，如 L-蛋氨酸、L-苏氨酸和甘氨酸，以及各种化学中间体。这些产品服务于多个终端市场，包括动物饲料和营养、个人护理和化妆品配方、药用成分和工业化学过程。</p>
</div><p>The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.</p>
<div class="lb-trans"><p>该公司在多个生产设施中运营，并设有专门致力于工艺创新和质量控制的内部研发中心。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Adlai Nortye</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Adlai Nortye</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Adlai Nortye Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Adlai Nortye 吗？</h2>
</div><p>Before you consider Adlai Nortye, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Adlai Nortye 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adlai Nortye wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Adlai Nortye 并不在名单上。</p>
</div><p>While Adlai Nortye currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Adlai Nortye 目前在分析师中获得了 &#34;持有&#34; 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Adlai Nortye (NASDAQ:ANL) 股价下跌 11.7% - 事件回顾